DUBLIN--(BUSINESS WIRE)--The "M2 Pharma Premium" newsletter has been added to ResearchAndMarkets.com's offering.
M2 Pharma brings you breaking news and information on the global pharmaceuticals industry, including online access to searchable news and archives, as well as emailed news bulletins.
M2 Pharma covers the global pharmaceuticals sector and related industries. The service includes 35-45 news stories per day, ranging from new drug launches, people moves and research and development and regulation.
It provides the latest business and financial news on the industry, including mergers, joint ventures, results and market activity.
Special attention is devoted to generic drug makers, including coverage of generic drug releases and news items on individual companies in the sector.
The service tracks developments in various therapy areas, with a strong focus on the areas of AIDS/HIV, Cardiovascular, Central Nervous System, Diabetes, Infectious Diseases, Inflammatory Diseases, Oncology, Respiratory and Vaccines.
The document also covers policy and regulation affecting the industry and the latest on research and development, as well as people moves and new appointments.
Covering research & development, policy & regulation, therapy areas, business & finance, people moves and the generic industry M2 Pharma Premium will keep you fully abreast of the developments throughout the day.
For more information about this newsletter visit https://www.researchandmarkets.com/r/2n13id
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
